Skip to main content

Table 2 Percentage description of type 2 diabetes (T2D), Impaired fasting glucose (IFG)/T2D, hypertension, waist-hip-ratio, waist circumference and body mass index by age group and by gender among 1623 study participants in Yaoundé, Cameroon, 2007

From: Risk factors of impaired fasting glucose and type 2 diabetes in Yaoundé, Cameroon: a cross sectional study

  

Men (n = 666)

 

Women (n = 957)

  

25-34

35-44

45-54

55-64

>65

p-value7

 

25-34

35-44

45-54

55-64

>65

p-value7

N

666

317

100

116

100

33

 

957

451

178

221

70

37

 

Variable

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

 

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

 

T2D1

28 (4.2)

3 (10.7)

1 (3.6)

8 (28.6)

14 (50.0)

2 (7.1)

<0.001

26 (2.7)

4 (15.4)

4 (15.4)

10 (38.5)

6 (23.1)

2 (7.7)

<0.001

IFG/T2D2

45 (6.8)

5 (11.1)

8 (17.8)

9 (20.0)

21 (46.7)

2 (4.4)

<0.001

48 (5.0)

9 (18.8)

8 (16.7)

20 (41.7)

8 (16.6)

3 (6.2)

<0.001

Hypertension3

203 (30.5)

37 (18.2)

21 (10.3)

58 (28.6)

59 (29.1)

28 (13.8)

<0.001

229 (23.9)

35 (15.3)

24 (10.5)

101 (44.1)

43 (18.8)

26 (11.4)

<0.001

Weight status4

              

Normal weight

314 (47.2)

195 (62.1)

38 (12.1)

33 (10.5)

32 (10.2)

16 (5.1)

 

279 (29.2)

185 (66.3)

38 (13.6)

28 (10.0)

15 (5.4)

13 (4.7)

 

Overweight

243 (36.5)

95 (39.1)

41 (16.9)

54 (22.2)

44 (18.1)

9 (3.7)

 

319 (33.3)

157 (49.2)

60 (18.8)

71 (22.3)

22 (6.9)

9 (2.8)

 

Obese

109 (16.4)

27 (24.8)

21 (19.3)

29 (26.6)

24 (22.0)

8 (7.3)

<0.001

359 (37.5)

109 (30.4)

80 (22.3)

122 (33.9)

33 (9.2)

15 (4.2)

<0.001

Waist-hip-ratio5

              

Normal

414 (62.2)

280 (67.6)

58 (14.0)

40 (9.7)

29 (7.0)

7 (1.7)

 

615 (64.3)

340 (55.3)

118 (19.2)

116 (18.9)

29 (4.7)

12 (1.9)

 

Elevated

252 (37.8)

37 (14.7)

42 (16.7)

76 (30.2)

71 (28.2)

26 (10.3)

<0.001

342 (35.7)

111 (32.5)

60 (17.5)

105 (30.7)

41 (12.0)

25 (7.3)

<0.001

Waist circumference6

              

Normal

485 (72.8)

287 (59.2)

64 (13.2)

65 (13.4)

52 (10.7)

17 (3.5)

 

258 (27.0)

185 (71.7)

40 (15.5)

21 (8.1)

8 (3.1)

4 (1.6)

 

Increased risk

98 (14.7)

23 (23.5)

17 (17.4)

23 (23.5)

28 (28.6)

7 (7.1)

 

215 (22.5)

113 (52.6)

33 (15.4)

43 (20.0)

15 (7.0)

11 (5.1)

 

Elevated

83 (12.5)

7 (8.4)

19 (22.9)

28 (33.7)

20 (24.1)

9 (10.8)

<0.001

484 (50.6)

153 (31.6)

105 (21.7)

157 (32.4)

47 (9.7)

22 (4.6)

<0.001

  1. 1FCG > =7.0 mmol/l and /or on diabetes medication.
  2. 2FCG > =6.1 mmol/l and /or on diabetes medication.
  3. 3SBP ≥ 140 and /or DBP ≥ 90 mmHg and / or on hypertensive medication.
  4. 4Normal weight (18.5Kg/m2 ≤ BMI < 25Kg/m2), overweight (25Kg/m2 ≤ BMI < 30Kg/m2) and obese (BMI ≥ 30Kg/m2).
  5. 5Normal waist-hip-ratio < 1.0 for men and <0.85 for women and elevated waist-hip-ratio >1.0 for men and >0.85 for women.
  6. 6Normal waist circumference < 94 cm for men and <80 cm for women, increased risk (94 cm > WC < 102 cm) for men and (80 cm > WC < 88 cm) for women and elevated ≥102 cm for men and ≥ 88 cm for women.